NO821167L - Uloeselig, tverrbundet cytotoxisk oxydase-peroxydasesystem - Google Patents

Uloeselig, tverrbundet cytotoxisk oxydase-peroxydasesystem

Info

Publication number
NO821167L
NO821167L NO821167A NO821167A NO821167L NO 821167 L NO821167 L NO 821167L NO 821167 A NO821167 A NO 821167A NO 821167 A NO821167 A NO 821167A NO 821167 L NO821167 L NO 821167L
Authority
NO
Norway
Prior art keywords
oxydase
cytotoxic
insulated
bonded
cross
Prior art date
Application number
NO821167A
Other languages
English (en)
Other versions
NO158004B (no
NO158004C (no
Inventor
Johnathan L Kiel
Original Assignee
Johnathan L Kiel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnathan L Kiel filed Critical Johnathan L Kiel
Publication of NO821167L publication Critical patent/NO821167L/no
Publication of NO158004B publication Critical patent/NO158004B/no
Publication of NO158004C publication Critical patent/NO158004C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • A61K38/385Serum albumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/18Multi-enzyme systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • C12Y111/01007Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO821167A 1981-04-07 1982-04-06 Fremgangsmaate for fremstilling av et preparat med cytolytisk aktivitet. NO158004C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/251,694 US4486408A (en) 1981-04-07 1981-04-07 Insoluble crosslinked cytotoxic oxidase-peroxidase system

Publications (3)

Publication Number Publication Date
NO821167L true NO821167L (no) 1982-10-08
NO158004B NO158004B (no) 1988-03-21
NO158004C NO158004C (no) 1988-06-29

Family

ID=22953019

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821167A NO158004C (no) 1981-04-07 1982-04-06 Fremgangsmaate for fremstilling av et preparat med cytolytisk aktivitet.

Country Status (13)

Country Link
US (1) US4486408A (no)
EP (1) EP0062434B1 (no)
JP (1) JPS57177694A (no)
AR (1) AR229260A1 (no)
AT (1) ATE15813T1 (no)
AU (1) AU556620B2 (no)
CA (1) CA1187791A (no)
DE (1) DE3266476D1 (no)
DK (1) DK155082A (no)
IL (1) IL65382A (no)
IN (1) IN156471B (no)
NO (1) NO158004C (no)
ZA (1) ZA821924B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
EP0236610A1 (en) * 1986-03-13 1987-09-16 Laclede Professional Products, Inc. Enzymatic bandages and pads
SE8500341L (sv) * 1985-01-24 1986-07-25 Pharmacia Ab Desinfektionssats samt sett for desinfektion
US4974929A (en) * 1987-09-22 1990-12-04 Baxter International, Inc. Fiber optical probe connector for physiologic measurement devices
EP0361908A3 (en) * 1988-09-28 1990-09-05 Ideon Corporation Combination enzyme immunotherapeutics
FR2646777B1 (fr) * 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
US5486360A (en) * 1993-04-22 1996-01-23 St. Joseph Health Centre Method of treating tumour cells using catalase
EP0670040A1 (en) * 1993-09-22 1995-09-06 Baxter Diagnostics Inc. Immobilization of chemically cross-linked proteins on solid supports
US7192766B2 (en) * 2001-10-23 2007-03-20 Medtronic Minimed, Inc. Sensor containing molded solidified protein
CN103781905A (zh) 2011-07-06 2014-05-07 加利福尼亚大学董事会 多酶纳米复合物
WO2023200842A1 (en) * 2022-04-13 2023-10-19 Exoxemis, Inc. Compositions and methods for treating solid cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004979A (en) * 1968-03-29 1977-01-25 Agence Nationale De Valorisation De La Recherche (Anvar) Preparation of active proteins cross-linked to inactive proteins
US4178362A (en) * 1969-06-03 1979-12-11 Telec S.A. Enzymatic dentifrices
US3638558A (en) * 1970-03-26 1972-02-01 Burger King Corp Cooking apparatus for comestibles immersed in heated oil
JPS528795B2 (no) * 1971-12-30 1977-03-11
DE2214442C3 (de) * 1972-03-24 1981-09-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Überführung von Glucose in Gluconsäure
DE2307904A1 (de) * 1973-02-17 1974-08-29 Hoechst Ag Verwendung von katalasefreien oder katalsearmen glucoseoxidase-praeparaten als zytostatikum fuer maligne zellen
DK146942C (da) * 1978-04-19 1984-07-30 Novo Industri As Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
DE2911192A1 (de) * 1979-03-22 1980-10-02 Boehringer Sohn Ingelheim Neuartiges immobilisiertes glucoseoxidase-katalasepraeparat und seine verwendung zur enzymatischen glucoseoxidation

Also Published As

Publication number Publication date
AU556620B2 (en) 1986-11-13
EP0062434A1 (en) 1982-10-13
CA1187791A (en) 1985-05-28
US4486408A (en) 1984-12-04
DK155082A (da) 1982-10-08
IL65382A0 (en) 1982-05-31
IL65382A (en) 1986-04-29
ZA821924B (en) 1983-04-27
AU8173982A (en) 1982-10-14
JPS57177694A (en) 1982-11-01
NO158004B (no) 1988-03-21
ATE15813T1 (de) 1985-10-15
DE3266476D1 (en) 1985-10-31
AR229260A1 (es) 1983-07-15
EP0062434B1 (en) 1985-09-25
NO158004C (no) 1988-06-29
IN156471B (no) 1985-08-10

Similar Documents

Publication Publication Date Title
IT8222200A0 (it) Fascetta stringitubo.
IT8223939A0 (it) Raccordo per catetere.
NO820795L (no) Fremgangsmaate for mikroinnkapsling.
FI821696A0 (fi) Hydrodynamiskt smoerjsystem foer kolvanordningar, saerskilt foer stirling-motorer
FI822696A0 (fi) Sporthjaelm, saerskilt foer ishockey
NO821167L (no) Uloeselig, tverrbundet cytotoxisk oxydase-peroxydasesystem
FI832065A0 (fi) Traog, saerskilt foer livsmedel
IT1207273B (it) Raccordo per tubo.
FI813461L (fi) Arbetsbord, speciellt foer hopsaettningsarbete
NO822616L (no) Tenningssystem.
FI822452A0 (fi) Stockback, speciellt foer sportgevaer
FI832657A (fi) Stomme, speciellt foer moebler
NO802393L (no) Styring for roerforbindelse.
IL65045A0 (en) Pipes for irrigation
FI821091A0 (fi) Behaollare foer vaetskor, foeretraedesvis foer drycker
NO822655L (no) Skruesystem.
ES516880A0 (es) Procedimiento de preparar derivados de p-acilaminofenol.
FI834289A (fi) Medbringare foer en draganordning.
IT8118112A0 (it) Dispositivo fresatubi.
ES521598A0 (es) Procedimiento de preparar derivados piridotienopiridacinicos.
FI824465L (fi) Vulkaniserbara, epoxider innehaollande etylenkopolymerer
NO822783L (no) Ammunisjons-haandteringssystem.
ES511884A0 (es) "procedimiento de preparar compuestos beta-lactamicos".
IT8124020A0 (it) Procedimento per preparare difenil-derivati.
NO158556C (no) Maksimum anvisende termometer til engangsbruk.